Results 21 to 30 of about 94 (81)

Biotecnología y sistemas de salud en los países en vía de desarrollo

Repertorio de Medicina y Cirugía, 2013
Se analizan las relaciones y los retos que surgen entre la investigación académica y la industria biotecnológica en la promoción del acceso a esta tecnología aplicada a la salud en países en vía de desarrollo, partiendo de una revisión teórica sobre las ...
Diana Rocío Bemal Camargo, Nancy Milena Bemal Camargo   +1 more
doaj   +1 more source

La e-salud. Hacia la medicina 5P: medicina personalizada, precisa, preventiva, predictiva y participativa

, 2022
Proyecto de Investigación B-SEJ-213-UGR18 “Retos de la modernización de la asistencia sanitaria en Andalucía: Cohesión interterritorial, envejecimiento y revolución digital. Proyectos I+D+i del Programa Operativo FEDER 2018.
Monereo Moreno, Isabel, Moreno Vida, María de las Nieves   +1 more
openaire   +1 more source

First‐trimester prediction and prevention of preterm pre‐eclampsia in women with chronic hypertension

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 5, Page 613-622, May 2026.
ABSTRACT Objectives To evaluate the effect of aspirin on gestational age at delivery due to preterm pre‐eclampsia (PE) in women with chronic hypertension (CH), to assess the predictive performance of the Fetal Medicine Foundation (FMF) first‐trimester competing‐risks model for preterm PE in this high‐risk group and to evaluate how parity, previous PE ...
D. L. Rolnik, S. Gil‐Pugliese, A. Syngelaki, E. Bujold, D. Wright, L. C. Poon, K. H. Nicolaides, ASPRE and SPREE Collaborators, C. de Paco Matallana, D. Janga, E. Greco, F. S. Molina, G. Papaioannou, H. Meiri, J. C. Jani, K. Maclagan, K. Tenenbaum‐Gavish, M. Singh, M. Y. Tan, N. O'Gorman, N. Persico, R. Akolekar, S. Cicero, W. Plasencia   +23 more
wiley   +1 more source

Inteligencia artificial y su uso en el diagnóstico: ¿El fin del Ars médico?

Revista Chilena de Salud Pública
La inteligencia artificial (IA) ha irrumpido en la medicina, transformando la forma en que se diagnostican y tratan las enfermedades. Si bien la IA promete aumentar la eficiencia y reducir los errores diagnósticos, plantea interrogantes sobre si puede ...
Jorge Gallardo Cochifas
doaj   +1 more source

ABO blood group A transferases catalyze the biosynthesis of FORS blood group FORS1 antigen upon deletion of exon 3 or 4

Blood Advances, 2017
: Evolutionarily related ABO and GBGT1 genes encode, respectively, A and B glycosyltransferases (AT and BT) and Forssman glycolipid synthase (FS), which catalyze the biosynthesis of A and B, and Forssman (FORS1) oligosaccharide antigens responsible for ...
Miyako Yamamoto, Emili Cid, Fumiichiro Yamamoto   +2 more
doaj   +1 more source

Successional and native forests predict the occurrence and infection status of Chagas disease vectors in Panama

Journal of Applied Ecology, Volume 63, Issue 1, January 2026.
Findings here show that successional forest predicts greater kissing bug infestation risk in palm trees, whereas native forest predicts lower kissing bug occurrence but greater infection with T. cruzi. These insights can guide land use planning towards vegetation management practices that help minimize T. cruzi transmission risks for rural communities.
Juliana Hoyos, Azael Saldaña, Sonia Altizer, Vanessa Pineda, Kadir Gonzalez, Jose E. Calzada, Raissa Nogueira de Brito, Susan Tanner, Daniel Mendieta, Alberto Cumbrera, Nicole L. Gottdenker   +10 more
wiley   +1 more source

Ecologic Traits Analysis for Identifying Rodent Hosts for Arenavirus and Hepacivirus in the Americas

Biotropica, Volume 57, Issue 6, November 2025.
Over half of emerging human pathogens originate from wildlife, with rodents serving as key zoonotic hosts. This study used ecological trait‐based models to identify rodent traits associated with arenavirus and hepacivirus infections and detect potential host species across the Americas, our models achieve high predictive accuracy (AUC = 0.92–0.96).
María del Carmen Villalobos‐Segura, Oscar Rico‐Chavéz, Gerardo Suzán, Andrea Chaves   +3 more
wiley   +1 more source

Screening for pre‐eclampsia using pregnancy‐associated plasma protein‐A or placental growth factor measurements in blood samples collected at 8–14 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 567-574, May 2025.
ABSTRACT Objectives To assess the value of pregnancy‐associated plasma protein‐A (PAPP‐A) in screening for preterm pre‐eclampsia (PE) (delivery < 37 weeks' gestation) measured in maternal blood samples collected before 11 weeks, and to compare the screening performance of PAPP‐A with that of placental growth factor (PlGF) from blood samples collected ...
L. Rode, A. Wright, D. Wright, M. Overgaard, L. Sperling, P. Sandager, P. Nørgaard, F. S. Jørgensen, H. Zingenberg, I. Riishede, A. Tabor, C. K. Ekelund, the PRESIDE Study Group, M. R. Andersen, L. Bathum, C. A. Juel Jensen, C. S. Knudsen, N. G. Pedersen, K. Pihl, C. Vedel, H. Skov, S. R. Wagner   +21 more
wiley   +1 more source

N‐terminal pro B‐type natriuretic peptide as biomarker to predict pre‐eclampsia and maternal–fetal complications

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 447-455, April 2025.
ABSTRACT Objective A soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio cut‐off of 38 is currently considered optimal for ruling out pre‐eclampsia (PE); however, implementation of this ratio in clinical practice is limited.
M. N. Nan, C. Garrido‐Giménez, Á. Garcia‐Osuna, P. Garcia Manau, J. Ullmo, J. Mora, O. Sanchez‐Garcia, J. Platero, M. Cruz‐Lemini, E. Llurba, on behalf of the EuroPE working group, M. Vila‐Cortés, M. J. Pelegay, M. Ricart, B. Muñoz‐Abellana, X. Gabaldó Barrios   +15 more
wiley   +1 more source

Routine 36‐week scan: prediction of small‐for‐gestational‐age neonate

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 1, Page 20-29, January 2025.
ABSTRACT Objectives First, to compare the predictive performance of routine ultrasonographic estimated fetal weight (EFW) at 31 + 0 to 33 + 6 and 35 + 0 to 36 + 6 weeks' gestation for delivery of a small‐for‐gestational‐age (SGA) neonate. Second, to compare the predictive performance of EFW at 36 weeks' gestation for SGA vs fetal growth restriction ...
S. Adjahou, A. Syngelaki, M. Nanda, D. Papavasileiou, R. Akolekar, K. H. Nicolaides   +5 more
wiley   +1 more source